bluuebunny/crossref_metadata_2025 huggingface dataset:
Supplementary Figure 3 from β-Mannosylceramide Activates Type I Natural Killer T Cells to Induce Tumor Immunity without Inducing Long-Term Functional Anergy
Authors: O'Konek Jessica J. , Kato Shingo , Takao Satomi , Izhak Liat , Xia Zheng , Illarionov Petr , Besra Gurdyal S. , Terabe Masaki , Berzofsky Jay A.
Published: April 2023

PDF file, 1823K, Mice were injected i.p. with 2.4 nmol (2 ug) of a-GalCer, b-ManCer or vehicle control. Splenocytes were harvested and restimulated in vitro with 100 nM a-GalCer, 500 nM b-ManCer or vehicle. IFN-g in culture supernatants was measured after 48 hours of stimulation. The concentrations of IFN-g in the supernatants (upper panels) and fold change over vehicle stimulated control to account for the variable backgrounds among groups (lower panels) at indicated time points are shown. Representatives of at least 2 replicate experiments are shown. Bars represent mean plus-minus SD; *, statistically significantly different from vehicle control stimulation; #, statistically significant from corresponding stimulation in vehicle pretreated group p<0.05.
Supplementary Table 1 from Cyclophosphamide Induces a Type I Interferon–Associated Sterile Inflammatory Response Signature in Cancer Patients' Blood Cells: Implications for Cancer Chemoimmunotherapy
Authors: Moschella Federica , Torelli Giovanni Fernando , Valentini Mara , Urbani Francesca , Buccione Carla , Petrucci Maria Teresa , Natalino Fiammetta , Belardelli Filippo , Foà Robin , Proietti Enrico
Published: April 2023

PDF file - 79K, Patients' characteristics.
Supplementary Figure 1 from Universal Cancer Peptide-Based Therapeutic Vaccine Breaks Tolerance against Telomerase and Eradicates Established Tumor
Authors: Dosset Magalie , Godet Yann , Vauchy Charline , Beziaud Laurent , Lone Yu Chun , Sedlik Christine , Liard Christelle , Levionnois Emeline , Clerc Bertrand , Sandoval Federico , Daguindau Etienne , Wain-Hobson Simon , Tartour Eric , Langlade-Demoyen Pierre , Borg Christophe , Adotévi Olivier
Published: April 2023

PDF file - 51K, Isolation of UCP4-specific CD4 Th1 cell clone from a cancer patient
Supplementary Table 1 from Inhibition of GSK3B Bypass Drug Resistance of p53-Null Colon Carcinomas by Enabling Necroptosis in Response to Chemotherapy
Authors: Grassilli Emanuela , Narloch Robert , Federzoni Elena , Ianzano Leonarda , Pisano Fabio , Giovannoni Roberto , Romano Gabriele , Masiero Laura , Leone Biagio Eugenio , Bonin Serena , Donada Marisa , Stanta Giorgio , Helin Kristian , Lavitrano Marialuisa
Published: April 2023

Supplementary Table 1 - PDF file 22K, Known genetic alterations of the different colon carcinoma cell lines used in the paper
Supplementary Figures S1 - S6 from Inhibition of Melanoma Growth by Small Molecules That Promote the Mitochondrial Localization of ATF2
Authors: Varsano Tal , Lau Eric , Feng Yongmei , Garrido Marine , Milan Loribelle , Heynen-Genel Susanne , Hassig Christian A. , Ronai Ze'ev A.
Published: April 2023

Supplementary Figures S1 - S6 - PDF file 945K, Supplementary Figure S1. Effect of select compounds on ATF2 nuclear-mitochondrial Translocation; Supplementary Figure S2. SBI-0089410 or SBI-0087702 do not affect the subcellular localization of Stat3 or beta-catenin. Supplementary Figure S3. The expression of ATF252E attenuates apoptosis induced by SBI-0089410 or SBI-0087702; Supplementary Figure S4. SBI-0089410 or SBI-0087702-induced inhibition of cell motility and cell death are reversed by the stable expression of ATF252E; Supplementary Figure S5. itochondrial potential changes induced by SBI-0089410 or SBI-0087702 in melanoma cells; Supplementary Figure S6. The effect of SBI-0089410 or SBI-0087702 on ATF2 phosphorylation, PKC translocation and activation, and the viability of PLX4032-resistant melanoma cell lines.
Supplementary Figure 5 from Inhibition of GSK3B Bypass Drug Resistance of p53-Null Colon Carcinomas by Enabling Necroptosis in Response to Chemotherapy
Authors: Grassilli Emanuela , Narloch Robert , Federzoni Elena , Ianzano Leonarda , Pisano Fabio , Giovannoni Roberto , Romano Gabriele , Masiero Laura , Leone Biagio Eugenio , Bonin Serena , Donada Marisa , Stanta Giorgio , Helin Kristian , Lavitrano Marialuisa
Published: April 2023

Supplementary Figure 5 - PDF file 219K, tAIF released from mitochondria upon 5FU treatment in GSK3B-silenced HCT116p53KO cells mediates drug-induced cell death
Supplementary Figure 1 from Inhibition of GSK3B Bypass Drug Resistance of p53-Null Colon Carcinomas by Enabling Necroptosis in Response to Chemotherapy
Authors: Grassilli Emanuela , Narloch Robert , Federzoni Elena , Ianzano Leonarda , Pisano Fabio , Giovannoni Roberto , Romano Gabriele , Masiero Laura , Leone Biagio Eugenio , Bonin Serena , Donada Marisa , Stanta Giorgio , Helin Kristian , Lavitrano Marialuisa
Published: April 2023

Supplementary Figure 1 - PDF file 450K, Identification and validation of the genes supporting drug 4 resistance by shRNA-mediated phenotype screen
Supplementary Figures 1 - 3 from Paracrine Receptor Activation by Microenvironment Triggers Bypass Survival Signals and ALK Inhibitor Resistance in EML4-ALK Lung Cancer Cells
Authors: Yamada Tadaaki , Takeuchi Shinji , Nakade Junya , Kita Kenji , Nakagawa Takayuki , Nanjo Shigeki , Nakamura Takahiro , Matsumoto Kunio , Soda Manabu , Mano Hiroyuki , Uenaka Toshimitsu , Yano Seiji
Published: April 2023

PDF file, 225KB, 1. EGFR ligands induce resistance to ALK inhibitors in a dose dependent manner in H2228 cells 2.H2228 cells were highly sensitive to siRNAs specific for ALK, whereas HGF and/or EGFR ligands (EGF, TGF-α, and HB-EGF) reduced the sensitivity of siRNAs specific for ALK 3.Induction of apoptosis in H2228 and H3122 cells by crizotinib 4.In MANA2 cells, HGF and EGFR ligands trigger ALK inhibitor resistance via Met and EGFR, respectively
Supplementary Table 2 from Overexpression of Ecdysoneless in Pancreatic Cancer and Its Role in Oncogenesis by Regulating Glycolysis
Authors: Dey Parama , Rachagani Satyanarayana , Chakraborty Subhankar , Singh Pankaj K. , Zhao Xiangshan , Gurumurthy Channabasavaiah Basavaraju , Anderson Judy M. , Lele Subodh , Hollingsworth Michael A. , Band Vimla , Batra Surinder K.
Published: April 2023

XLSX file - 11K, Variation in Ecd expression with grade and stage of Pancreatic Cancer
Supplementary Figure 2 from FANCD2 Is a Potential Therapeutic Target and Biomarker in Alveolar Rhabdomyosarcoma Harboring the PAX3–FOXO1 Fusion Gene
Authors: Singh Mamata , Leasure Justin M. , Chronowski Christopher , Geier Brian , Bondra Kathryn , Duan Wenrui , Hensley Lauren A. , Villalona-Calero Miguel , Li Ning , Vergis Anthony M. , Kurmasheva Raushan T. , Shen Changxian , Woods Gary , Sebastian Nikhil , Fabian Denise , Kaplon Rita , Hammond Sue , Palanichamy Kamalakannan , Chakravarti Arnab , Houghton Peter J.
Published: April 2023

PDF file - 147KB, Changes in mTOR signaling and FANCD2 levels in treatment groups.
Supplementary Figure Legend from Overexpression of Ecdysoneless in Pancreatic Cancer and Its Role in Oncogenesis by Regulating Glycolysis
Authors: Dey Parama , Rachagani Satyanarayana , Chakraborty Subhankar , Singh Pankaj K. , Zhao Xiangshan , Gurumurthy Channabasavaiah Basavaraju , Anderson Judy M. , Lele Subodh , Hollingsworth Michael A. , Band Vimla , Batra Surinder K.
Published: April 2023

PDF file - 84K
Supplementary Table B from Inhibitors Targeting Mitosis: Tales of How Great Drugs against a Promising Target Were Brought Down by a Flawed Rationale
Authors: Komlodi-Pasztor Edina , Sackett Dan L. , Fojo Antonio Tito
Published: April 2023

PDF file - 88K
Supplementary Figure 1 from Overexpression of Ecdysoneless in Pancreatic Cancer and Its Role in Oncogenesis by Regulating Glycolysis
Authors: Dey Parama , Rachagani Satyanarayana , Chakraborty Subhankar , Singh Pankaj K. , Zhao Xiangshan , Gurumurthy Channabasavaiah Basavaraju , Anderson Judy M. , Lele Subodh , Hollingsworth Michael A. , Band Vimla , Batra Surinder K.
Published: April 2023

PDF file - 1365K, Ecd expression in pancreatic cancer cell lines
Supplementary Figure 2 from Concomitant BRAF and PI3K/mTOR Blockade Is Required for Effective Treatment of BRAFV600E Colorectal Cancer
Authors: Coffee Erin M. , Faber Anthony C. , Roper Jatin , Sinnamon Mark J. , Goel Gautam , Keung Lily , Wang Wei Vivian , Vecchione Loredana , de Vriendt Veerle , Weinstein Barbara J. , Bronson Roderick T. , Tejpar Sabine , Xavier Ramnik J. , Engelman Jeffrey A. , Martin Eric S. , Hung Kenneth E.
Published: April 2023

Supplementary Figure 2 PDF file 152K, APC tumors do not recapitulate the sessile serrated CRC pathway
Supplementary Figures 2 - 4 from Ras-Driven Transcriptome Analysis Identifies Aurora Kinase A as a Potential Malignant Peripheral Nerve Sheath Tumor Therapeutic Target
Authors: Patel Ami V. , Eaves David , Jessen Walter J. , Rizvi Tilat A. , Ecsedy Jeffrey A. , Qian Mark G. , Aronow Bruce J. , Perentesis John P. , Serra Eduard , Cripe Timothy P. , Miller Shyra J. , Ratner Nancy
Published: April 2023

PDF file, 595K, Supplementary Figure S2. Gene Interaction Network of 339 Ras-Driven Genes Differentially Expressed in Mouse or Human Neurofibromas or MPNSTs. Supplementary Figure S3. Dot plot showing qPCR DNA-copy number results for AURKA gene locus in 37 samples analyzed. Supplementary Figure S4. Expressional down regulation or inhibition of Aurora Kinase Reduces Survival in MPNST Cells.
Supplementary Figure 6 from Functional Profiling of Receptor Tyrosine Kinases and Downstream Signaling in Human Chondrosarcomas Identifies Pathways for Rational Targeted Therapy
Authors: Zhang Yi-Xiang , van Oosterwijk Jolieke G. , Sicinska Ewa , Moss Samuel , Remillard Stephen P. , van Wezel Tom , Bühnemann Claudia , Hassan Andrew B. , Demetri George D. , Bovée Judith V.M.G. , Wagner Andrew J.
Published: April 2023

Supplementary Figure 6 - PDF file 137K, Combinatorial effects of BEZ235 and MEK inhibitor ARRY-142886 in SW1353 cells with NRAS mutation
Supplementary Figure 2 from Molecular Determinants of Retinoic Acid Sensitivity in Pancreatic Cancer
Authors: Gupta Sonal , Pramanik Dipankar , Mukherjee Radha , Campbell Nathaniel R. , Elumalai Sathyanarayanan , de Wilde Roeland F. , Hong Seung-Mo , Goggins Michael G. , De Jesus-Acosta Ana , Laheru Daniel , Maitra Anirban
Published: April 2023

PDF file - 89K
Appendix from Identification of Prognosis-Relevant Subgroups in Patients with Chemoresistant Triple-Negative Breast Cancer
Authors: Yu Ke-Da , Zhu Rui , Zhan Ming , Rodriguez Angel A. , Yang Wei , Wong Stephen , Makris Andreas , Lehmann Brian D. , Chen Xi , Mayer Ingrid , Pietenpol Jennifer A. , Shao Zhi-Ming , Symmans W. Fraser , Chang Jenny C.
Published: April 2023

Appendix PDF file 120K, Appendix methods
Related Article from Zeroing in on ROS1 Rearrangements in Non–Small Cell Lung Cancer
Authors: Stumpfova Magda , Jänne Pasi A.
Published: April 2023

Related Article from Zeroing in on ROS1 Rearrangements in Non–Small Cell Lung Cancer
Supplementary Figure Legends 1-7 from Use of [11C]Choline PET-CT as a Noninvasive Method for Detecting Pelvic Lymph Node Status from Prostate Cancer and Relationship with Choline Kinase Expression
Authors: Contractor Kaiyumars , Challapalli Amarnath , Barwick Tara , Winkler Mathias , Hellawell Giles , Hazell Steve , Tomasi Giampaolo , Al-Nahhas Adil , Mapelli Paola , Kenny Laura M. , Tadrous Paul , Coombes R. Charles , Aboagye Eric O. , Mangar Stephen
Published: April 2023

PDF file - 56K
Supplementary Figure 7 from Use of [11C]Choline PET-CT as a Noninvasive Method for Detecting Pelvic Lymph Node Status from Prostate Cancer and Relationship with Choline Kinase Expression
Authors: Contractor Kaiyumars , Challapalli Amarnath , Barwick Tara , Winkler Mathias , Hellawell Giles , Hazell Steve , Tomasi Giampaolo , Al-Nahhas Adil , Mapelli Paola , Kenny Laura M. , Tadrous Paul , Coombes R. Charles , Aboagye Eric O. , Mangar Stephen
Published: April 2023

PDF file - 46K
Supplementary Figure Legend from Antiviral and Antitumor T-cell Immunity in Patients Treated with GM-CSF–Coding Oncolytic Adenovirus
Authors: Kanerva Anna , Nokisalmi Petri , Diaconu Iulia , Koski Anniina , Cerullo Vincenzo , Liikanen Ilkka , Tähtinen Siri , Oksanen Minna , Heiskanen Raita , Pesonen Saila , Joensuu Timo , Alanko Tuomo , Partanen Kaarina , Laasonen Leena , Kairemo Kalevi , Pesonen Sari , Kangasniemi Lotta , Hemminki Akseli
Published: April 2023

PDF file - 77K
Supplementary Table 2 from Chromosomal Instability Substantiates Poor Prognosis in Patients with Diffuse Large B-cell Lymphoma
Authors: Bakhoum Samuel F. , Danilova Olga V. , Kaur Prabhjot , Levy Norman B. , Compton Duane A.
Published: April 2023

PDF file - 71K
Supplementary Table 2 from Functional, Genetic, and Epigenetic Aspects of Base and Nucleotide Excision Repair in Colorectal Carcinomas
Authors: Slyskova Jana , Korenkova Vlasta , Collins Andrew R. , Prochazka Pavel , Vodickova Ludmila , Svec Jiri , Lipska Ludmila , Levy Miroslav , Schneiderova Michaela , Liska Vaclav , Holubec Lubos , Kumar Rajiv , Soucek Pavel , Naccarati Alessio , Vodicka Pavel
Published: April 2023

PDF file, 59K, Table shows list of genes analyzed by MSP with their respective primers sequences and reaction conditions.
Supplemental Figure 2 from Anticancer Effects of Niclosamide in Human Glioblastoma
Authors: Wieland Anja , Trageser Daniel , Gogolok Sabine , Reinartz Roman , Höfer Heike , Keller Mihaela , Leinhaas Anke , Schelle Ramona , Normann Sabine , Klaas Lil , Waha Andreas , Koch Philipp , Fimmers Rolf , Pietsch Torsten , Yachnis Anthony T. , Pincus David W. , Steindler Dennis A. , Brüstle Oliver , Simon Matthias , Glas Martin , Scheffler Björn
Published: April 2023

Niclosamide dose-response curves, supplementing data presented in Figure 2B.
Supplementary Figure Legend from Spleen Cells from Young but Not Old Immunized Mice Eradicate Large Established Cancers
Authors: Schreiber Karin , Arina Ainhoa , Engels Boris , Spiotto Michael T. , Sidney John , Sette Alessandro , Karrison Theodore G. , Weichselbaum Ralph R. , Rowley Donald A. , Schreiber Hans
Published: April 2023

PDF file, 61KB.
Supplementary Figure 2 from Spleen Cells from Young but Not Old Immunized Mice Eradicate Large Established Cancers
Authors: Schreiber Karin , Arina Ainhoa , Engels Boris , Spiotto Michael T. , Sidney John , Sette Alessandro , Karrison Theodore G. , Weichselbaum Ralph R. , Rowley Donald A. , Schreiber Hans
Published: April 2023

PDF file, 196KB, Loss of expression of the mutant p68 (mp68) rejection antigen by all 8101 variants that grew progressively in na�ve young mice but retention by 8101 tumor that developed in the old recipient.
Supplementary Table 5 from Biomarker Discovery in Non–Small Cell Lung Cancer: Integrating Gene Expression Profiling, Meta-analysis, and Tissue Microarray Validation
Authors: Botling Johan , Edlund Karolina , Lohr Miriam , Hellwig Birte , Holmberg Lars , Lambe Mats , Berglund Anders , Ekman Simon , Bergqvist Michael , Pontén Fredrik , König André , Fernandes Oswaldo , Karlsson Mats , Helenius Gisela , Karlsson Christina , Rahnenführer Jörg , Hengstler Jan G , Micke Patrick
Published: April 2023

PDF file - 28K, COX regression analysis for CADM1 protein expression in the Uppsala cohort
Supplemental Material Section S1 from miRNA Landscape in Stage I Epithelial Ovarian Cancer Defines the Histotype Specificities
Authors: Calura Enrica , Fruscio Robert , Paracchini Lara , Bignotti Eliana , Ravaggi Antonella , Martini Paolo , Sales Gabriele , Beltrame Luca , Clivio Luca , Ceppi Lorenzo , Di Marino Mariacristina , Fuso Nerini Ilaria , Zanotti Laura , Cavalieri Duccio , Cattoretti Giorgio , Perego Patrizia , Milani Rodolfo , Katsaros Dionyssios , Tognon Germana , Sartori Enrico , Pecorelli Sergio , Mangioni Costantino , D'Incalci Maurizio , Romualdi Chiara , Marchini Sergio
Published: April 2023

PDF file - 78K, Tissue sample collection.
Supplementary Figures 1 - 2, Table 1 from Multidrug Resistance–Linked Gene Signature Predicts Overall Survival of Patients with Primary Ovarian Serous Carcinoma
Authors: Gillet Jean-Pierre , Calcagno Anna Maria , Varma Sudhir , Davidson Ben , Bunkholt Elstrand Mari , Ganapathi Ram , Kamat Aparna A. , Sood Anil K. , Ambudkar Suresh V. , Seiden Michael V. , Rueda Bo R. , Gottesman Michael M.
Published: April 2023

PDF file, 1202KB, Supplementary Figure 1. Kaplan-Meier Survival Curves. Supplementary Figure 2. Kaplan-Meier Survival Curves. Supplementary Table 1. Univariate analysis of clinical covariates.
Supplementary Figure 4 from Combination Small Molecule MEK and PI3K Inhibition Enhances Uveal Melanoma Cell Death in a Mutant GNAQ- and GNA11-Dependent Manner
Authors: Khalili Jahan S. , Yu Xiaoxing , Wang Ji , Hayes Brendan C. , Davies Michael A. , Lizee Gregory , Esmaeli Bita , Woodman Scott E.
Published: April 2023

PDF file, 78K, Cell death assessment following combination MEKi + PI3Ki treatment in BIM siRNA targeted uveal melanoma cells.
Supplementary Table 4 from The Zinc Finger Gene ZIC2 Has Features of an Oncogene and Its Overexpression Correlates Strongly with the Clinical Course of Epithelial Ovarian Cancer
Authors: Marchini Sergio , Poynor Elizabeth , Barakat Richard R. , Clivio Luca , Cinquini Michela , Fruscio Robert , Porcu Luca , Bussani Cecilia , D’Incalci Maurizio , Erba Eugenio , Romano Michela , Cattoretti Giorgio , Katsaros Dionyssios , Koff Andrew , Luzzatto Lucio
Published: April 2023

PDF file, 82K, Univariate analysis. Linear regression analysis between histopathological features and ZIC2 expression. Units are 103 multiplied.
Related Article from Differential Role of BCL2 in Molecular Subtypes of Diffuse Large B-cell Lymphoma
Authors: Dunleavy Kieron , Wilson Wyndham H.
Published: April 2023

Related Article from Differential Role of BCL2 in Molecular Subtypes of Diffuse Large B-cell Lymphoma
Data Supplement from Functional p38 MAPK Identified by Biomarker Profiling of Pancreatic Cancer Restrains Growth through JNK Inhibition and Correlates with Improved Survival
Authors: Zhong Yi , Naito Yoshiki , Cope Leslie , Naranjo-Suarez Salvador , Saunders Tyler , Hong Seung-Mo , Goggins Michael G. , Herman Joseph M. , Wolfgang Christopher L. , Iacobuzio-Donahue Christine A.
Published: April 2023

Supplemental Figure 3. Dose Response Curves
Supplementary Table 2 from Clinical Significance of the Genetic Landscape of Pancreatic Cancer and Implications for Identification of Potential Long-term Survivors
Authors: Yachida Shinichi , White Catherine M. , Naito Yoshiki , Zhong Yi , Brosnan Jacqueline A. , Macgregor-Das Anne M. , Morgan Richard A. , Saunders Tyler , Laheru Daniel A. , Herman Joseph M. , Hruban Ralph H. , Klein Alison P. , Jones Siân , Velculescu Victor , Wolfgang Christopher L. , Iacobuzio-Donahue Christine A.
Published: April 2023

PDF file - 94K, Complete sequencing and IHC data for all 79 Patients
Supplementary Figure 5 from Mutual Regulation between Raf/MEK/ERK Signaling and Y-Box–Binding Protein-1 Promotes Prostate Cancer Progression
Authors: Imada Kenjiro , Shiota Masaki , Kohashi Kenichi , Kuroiwa Kentaro , Song YooHyun , Sugimoto Masaaki , Naito Seiji , Oda Yoshinao
Published: April 2023

Supplementary Figure 5 - Supplementary Figure 5. Densitometric analyses of Figure 4C - PDF file 83K, Protein expression level of Raf-1 in LNCaP and PC-3 cells transfected with control siRNA and not treated with cycloheximide (CHX) (A) or MG132 (B) was defined as 1. Bars, plus-minus s.d.; *P < 0.05 versus cells with transfected with control siRNA
Supplementary Figure 3 from Mutual Regulation between Raf/MEK/ERK Signaling and Y-Box–Binding Protein-1 Promotes Prostate Cancer Progression
Authors: Imada Kenjiro , Shiota Masaki , Kohashi Kenichi , Kuroiwa Kentaro , Song YooHyun , Sugimoto Masaaki , Naito Seiji , Oda Yoshinao
Published: April 2023

Supplementary Figure 3 - Supplementary Figure 3. Densitometric analyses of Figure 3B and 3D - PDF file 102K, Protein level of ERK1 and ERK2 in LNCaP and PC-3 cells transfected with control siRNA and not treated with cycloheximide (CHX) (A) or MG132 (B) was defined as 1. Bars, plus-minus s.d.; *P < 0.05 versus cells with transfected with control siRNA
Supplementary Figure 1 from Mutual Regulation between Raf/MEK/ERK Signaling and Y-Box–Binding Protein-1 Promotes Prostate Cancer Progression
Authors: Imada Kenjiro , Shiota Masaki , Kohashi Kenichi , Kuroiwa Kentaro , Song YooHyun , Sugimoto Masaaki , Naito Seiji , Oda Yoshinao
Published: April 2023

Supplementary Figure 1 - Supplementary Figure 1. Densitometric analyses of Figure 1D - PDF file 73K, Protein level of p-YB-1, p-ERK1 and p-ERK2 in LNCaP cells not treated with EGF and MEK inhibitors (U0126, PD98059) was defined as 1. Boxes, mean; bars, plus-minus s.d.; *P < 0.05 vesus non-treated cells
Supplementary Figure 7 from Targeted Therapy for BRAFV600E Malignant Astrocytoma
Authors: Nicolaides Theodore P. , Li Huifang , Solomon David A. , Hariono Sujatmi , Hashizume Rintaro , Barkovich Krister , Baker Suzanne J. , Paugh Barbara S. , Jones Chris , Forshew Tim , Hindley Guy F. , Hodgson J. Graeme , Kim Jung-Sik , Rowitch David H. , Weiss William A. , Waldman Todd A. , James C. David
Published: April 2023

PDF file - 78K
Supplementary Figure Legend from Elevation of c-FLIP in Castrate-Resistant Prostate Cancer Antagonizes Therapeutic Response to Androgen Receptor–Targeted Therapy
Authors: McCourt Clare , Maxwell Pamela , Mazzucchelli Roberta , Montironi Rodolfo , Scarpelli Marina , Salto-Tellez Manuel , O'Sullivan Joe M. , Longley Daniel B. , Waugh David J.J.
Published: April 2023

PDF file, 116KB.
Supplementary Figure 7 from Elevation of c-FLIP in Castrate-Resistant Prostate Cancer Antagonizes Therapeutic Response to Androgen Receptor–Targeted Therapy
Authors: McCourt Clare , Maxwell Pamela , Mazzucchelli Roberta , Montironi Rodolfo , Scarpelli Marina , Salto-Tellez Manuel , O'Sullivan Joe M. , Longley Daniel B. , Waugh David J.J.
Published: April 2023

PDF file, 80KB, Bar graphs illustrating the effect of SAHA, bicalutamide or their combined administration upon (A), the AR-target gene PSA or (B) the NF-κB target gene Bcl-2 in VCaP cells.
Supplementary Figure 3 from Randomized Phase Ib/II Trial of Rilotumumab or Ganitumab with Panitumumab versus Panitumumab Alone in Patients with Wild-type KRAS Metastatic Colorectal Cancer
Authors: Van Cutsem Eric , Eng Cathy , Nowara Elzbieta , Świeboda-Sadlej Anna , Tebbutt Niall C. , Mitchell Edith , Davidenko Irina , Stephenson Joe , Elez Elena , Prenen Hans , Deng Hongjie , Tang Rui , McCaffery Ian , Oliner Kelly S. , Chen Lisa , Gansert Jennifer , Loh Elwyn , Smethurst Dominic , Tabernero Josep
Published: April 2023

PDF file - 22K, Supplemental Fig. S3. Effect of cytoplasmic MET immunohistochemistry (IHC) staining on objective response rate in patients treated with panitumumab (pmab) plus rilotumumab (AMG 102) versus pmab plus placebo.
Supplementary Figure 5 from Elevation of c-FLIP in Castrate-Resistant Prostate Cancer Antagonizes Therapeutic Response to Androgen Receptor–Targeted Therapy
Authors: McCourt Clare , Maxwell Pamela , Mazzucchelli Roberta , Montironi Rodolfo , Scarpelli Marina , Salto-Tellez Manuel , O'Sullivan Joe M. , Longley Daniel B. , Waugh David J.J.
Published: April 2023

PDF file, 72KB, Characterization of differential AR and NF-κB activity in prostate cancer cell lines and the response to SAHA and bicalutamide.
Identification of FIG-ROS1 fusion in tumor ID 749 from Analysis of Receptor Tyrosine Kinase ROS1-Positive Tumors in Non–Small Cell Lung Cancer: Identification of a FIG-ROS1 Fusion
Authors: Rimkunas Victoria M. , Crosby Katherine E. , Li Daiqiang , Hu Yerong , Kelly Meghan E. , Gu Ting-Lei , Mack Jennifer S. , Silver Matthew R. , Zhou Xinmin , Haack Herbert
Published: April 2023

(A) Schematic representation of the genomic region containing fig and ros1. Probes set 1 derived from ros1 (orange) and the deleted region (green). Probe set 2 derived from ros1 (orange) and fig (green). (B,C) Yellow arrows point to split signals indicative of balanced translocation in the HCC78 cell line and white arrows point to intact chromosome. (D,F) In both U-118 MG and tumor ID 749 only the ros1 (orange) probe anneals and the deleted region (green probe) does not. (E,G) ros1 (orange) and fig (green) probes overlap indicating fig-ros1 fusion. (H)
Supplementary Figure 4 from Radioimmunotherapy of Fibroblast Activation Protein Positive Tumors by Rapidly Internalizing Antibodies
Authors: Fischer Eliane , Chaitanya Krishna , Wüest Thomas , Wadle Andreas , Scott Andrew M. , van den Broek Maries , Schibli Roger , Bauer Stefan , Renner Christoph
Published: April 2023

PDF file - 113K, Inhibition of FAP internalization mediated by ESC11 IgG1 in vitro
Supplementary Figure 3 from Radioimmunotherapy of Fibroblast Activation Protein Positive Tumors by Rapidly Internalizing Antibodies
Authors: Fischer Eliane , Chaitanya Krishna , Wüest Thomas , Wadle Andreas , Scott Andrew M. , van den Broek Maries , Schibli Roger , Bauer Stefan , Renner Christoph
Published: April 2023

PDF file - 15K, Epitope mapping by competitive binding to HT1080 huFAP+
Supplementary Figure Legend from Vandetanib in Children and Adolescents with Multiple Endocrine Neoplasia Type 2B Associated Medullary Thyroid Carcinoma
Authors: Fox Elizabeth , Widemann Brigitte C. , Chuk Meredith K. , Marcus Leigh , Aikin Alberta , Whitcomb Patricia O. , Merino Maria J. , Lodish Maya , Dombi Eva , Steinberg Seth M. , Wells Samuel A. , Balis Frank M.
Published: April 2023

PDF file - 67K
Supplementary Table 2 from Using Pharmacokinetic and Pharmacodynamic Data in Early Decision Making Regarding Drug Development: A Phase I Clinical Trial Evaluating Tyrosine Kinase Inhibitor, AEE788
Authors: Baselga José , Mita Alain C. , Schöffski Patrick , Dumez Herlinde , Rojo Frederico , Tabernero Josep , DiLea Clifford , Mietlowski William , Low Christie , Huang Jerry , Dugan Margaret , Parker Kathryn , Walk Eric , van Oosterom Allan , Martinelli Erika , Takimoto Chris H.
Published: April 2023

PDF file - 72K, Most Frequent Adverse Events (≥ 15%, any dose group) by Initial Dose Group (Safety Population)
Supplementary Table 1 from Using Pharmacokinetic and Pharmacodynamic Data in Early Decision Making Regarding Drug Development: A Phase I Clinical Trial Evaluating Tyrosine Kinase Inhibitor, AEE788
Authors: Baselga José , Mita Alain C. , Schöffski Patrick , Dumez Herlinde , Rojo Frederico , Tabernero Josep , DiLea Clifford , Mietlowski William , Low Christie , Huang Jerry , Dugan Margaret , Parker Kathryn , Walk Eric , van Oosterom Allan , Martinelli Erika , Takimoto Chris H.
Published: April 2023

PDF file - 50K, Primary Antibodies Used for Immunohistochemical Staining
Supplementary Table 3 from Phase I Safety, Pharmacokinetic, and Pharmacodynamic Study of SAR245408 (XL147), an Oral Pan-Class I PI3K Inhibitor, in Patients with Advanced Solid Tumors
Authors: Shapiro Geoffrey I. , Rodon Jordi , Bedell Cynthia , Kwak Eunice L. , Baselga Jose , Braña Irene , Pandya Shuchi S. , Scheffold Christian , Laird A. Douglas , Nguyen Linh T. , Xu Yi , Egile Coumaran , Edelman Gerald
Published: April 2023

PDF file - 96K, Reduction in PI3K pathway signaling in serial tumor biopsies.
Supplementary Table 2 from Lack of Estrogen Receptor-α Is Associated with Epithelial–Mesenchymal Transition and PI3K Alterations in Endometrial Carcinoma
Authors: Wik Elisabeth , Ræder Maria B. , Krakstad Camilla , Trovik Jone , Birkeland Even , Hoivik Erling A. , Mjos Siv , Werner Henrica M.J. , Mannelqvist Monica , Stefansson Ingunn M. , Oyan Anne M. , Kalland Karl H. , Akslen Lars A. , Salvesen Helga B.
Published: April 2023

PDF file - 59 KB, Overview of patient characteristics for the three cohorts collected and treated at Haukeland University Hospital, Bergen, Norway
Supplementary Table 1 from Lack of Estrogen Receptor-α Is Associated with Epithelial–Mesenchymal Transition and PI3K Alterations in Endometrial Carcinoma
Authors: Wik Elisabeth , Ræder Maria B. , Krakstad Camilla , Trovik Jone , Birkeland Even , Hoivik Erling A. , Mjos Siv , Werner Henrica M.J. , Mannelqvist Monica , Stefansson Ingunn M. , Oyan Anne M. , Kalland Karl H. , Akslen Lars A. , Salvesen Helga B.
Published: April 2023

PDF file - 70 KB, List of GEO Accession numbers for 111 tumors from external validation data set (GSE 2109, expO)
Supplementary Figure 5 from TP53 Mutation Spectrum in Breast Cancer Is Subtype Specific and Has Distinct Prognostic Relevance
Authors: Silwal-Pandit Laxmi , Vollan Hans Kristian Moen , Chin Suet-Feung , Rueda Oscar M. , McKinney Steven , Osako Tomo , Quigley David A. , Kristensen Vessela N. , Aparicio Samuel , Børresen-Dale Anne-Lise , Caldas Carlos , Langerød Anita
Published: April 2023

PDF file - 162KB, Figure S5. Boxplot diagram showing APOBEC3B mRNA expression levels as log intensity values in TP53 mutated and wildtype samples stratified by PAM50 subtypes. The bold black line represents the mean APOBEC3B expression value and the box represents 25th and 75th percentiles.
Supplementary Figure 1 from TP53 Mutation Spectrum in Breast Cancer Is Subtype Specific and Has Distinct Prognostic Relevance
Authors: Silwal-Pandit Laxmi , Vollan Hans Kristian Moen , Chin Suet-Feung , Rueda Oscar M. , McKinney Steven , Osako Tomo , Quigley David A. , Kristensen Vessela N. , Aparicio Samuel , Børresen-Dale Anne-Lise , Caldas Carlos , Langerød Anita
Published: April 2023

PDF file - 21KB, Figure S1. Flow diagram showing the number of patients included in the study.
Supplementary Figure Legends from A Pharmacokinetic/Pharmacodynamic Model of Tumor Lysis Syndrome in Chronic Lymphocytic Leukemia Patients Treated with Flavopiridol
Authors: Ji Jia , Mould Diane R. , Blum Kristie A. , Ruppert Amy S. , Poi Ming , Zhao Yuan , Johnson Amy J. , Byrd John C. , Grever Michael R. , Phelps Mitch A.
Published: April 2023

PDF file - 51 KB
Supplementary Figure 3 from Reverse-Phase Protein Array Profiling of Oropharyngeal Cancer and Significance of PIK3CA Mutations in HPV-Associated Head and Neck Cancer
Authors: Sewell Andrew , Brown Brandee , Biktasova Asel , Mills Gordon B. , Lu Yiling , Tyson Darren R. , Issaeva Natalia , Yarbrough Wendell G.
Published: April 2023

PDF file - 157KB, UMSCC-47 parental and stably overexpressing mutant or wild-type PI3KCA cells were treated with increasing concentrations of AKT (MK-2206) or dual PI3KCA/mTOR (BEZ-235) inhibitor, and cells survival was assessed after 7 days of treatment with trypan blue exclusion. Concentrations inhibiting growth by 50% are presented.
Supplementary Table 2 from LINE-1 Hypomethylation, DNA Copy Number Alterations, and CDK6 Amplification in Esophageal Squamous Cell Carcinoma
Authors: Baba Yoshifumi , Watanabe Masayuki , Murata Asuka , Shigaki Hironobu , Miyake Keisuke , Ishimoto Takatsugu , Iwatsuki Masaaki , Iwagami Shiro , Yoshida Naoya , Oki Eiji , Sakamaki Kentaro , Nakao Mitsuyoshi , Baba Hideo
Published: April 2023

PDF file - 55K, Signal counts of CDK6 and chromosome 7centromere in TE11 cells.
Supplementary Figure 6 from A Tumorigenic Factor Interactome Connected through Tumor Suppressor MicroRNA-198 in Human Pancreatic Cancer
Authors: Marin-Muller Christian , Li Dali , Bharadwaj Uddalak , Li Min , Chen Changyi , Hodges Sally E. , Fisher William E. , Mo Qianxing , Hung Mien-Chie , Yao Qizhi
Published: April 2023

Supplementary Figure 6 - PDF file 388K, miR-198 modulation reduces the tumorigenic functions of mesothelin-overexpressing pancreatic cancer cells in vitro and in vivo
Supplementary Figure 5 from A Tumorigenic Factor Interactome Connected through Tumor Suppressor MicroRNA-198 in Human Pancreatic Cancer
Authors: Marin-Muller Christian , Li Dali , Bharadwaj Uddalak , Li Min , Chen Changyi , Hodges Sally E. , Fisher William E. , Mo Qianxing , Hung Mien-Chie , Yao Qizhi
Published: April 2023

Supplementary Figure 5 - PDF file 212K, Construct details for miR-198 target analysis of MSLN CDS
Supplementary Figure 2 from Identification of Campath-1 (CD52) as Novel Drug Target in Neoplastic Stem Cells in 5q-Patients with MDS and AML
Authors: Blatt Katharina , Herrmann Harald , Hoermann Gregor , Willmann Michael , Cerny-Reiterer Sabine , Sadovnik Irina , Herndlhofer Susanne , Streubel Berthold , Rabitsch Werner , Sperr Wolfgang R. , Mayerhofer Matthias , Rülicke Thomas , Valent Peter
Published: April 2023

PDF file - 143K, Supplementary Figure S2A: Effects of alemtuzumab on growth of HL60 cells transfected with empty vector or NRAS Q61K Supplementary Figure S2B: Effects of alemtuzumab in combination with IgG on growth of MDS and AML stem cells Supplementary Figure S2C: Correlation between CD52 surface expression and the cytotoxic effect of alemtuzumab.
Supplementary Figure 5 from In Situ Tumor PD-L1 mRNA Expression Is Associated with Increased TILs and Better Outcome in Breast Carcinomas
Authors: Schalper Kurt A. , Velcheti Vamsidhar , Carvajal Daniel , Wimberly Hallie , Brown Jason , Pusztai Lajos , Rimm David L.
Published: April 2023

PDF file - 1784K, Figure S5. Validation of the prognostic value of PD-L1 mRNA expression in publicly available breast cancer datasets.
Supplementary Table S4 from The Activation of the WNT Signaling Pathway Is a Hallmark in Neurofibromatosis Type 1 Tumorigenesis
Authors: Luscan Armelle , Shackleford Ghjuvan'Ghjacumu , Masliah-Planchon Julien , Laurendeau Ingrid , Ortonne Nicolas , Varin Jennifer , Lallemand François , Leroy Karen , Dumaine Valérie , Hivelin Mikael , Borderie Didier , De Raedt Thomas , Valeyrie-Allanore Laurence , Larousserie Frédérique , Terris Benoît , Lantieri Laurent , Vidaud Michel , Vidaud Dominique , Wolkenstein Pierre , Parfait Béatrice , Bièche Ivan , Massaad Charbel , Pasmant Eric
Published: April 2023

PDF file 100K, mRNA levels of 32 identified genes in 10 dermal neurofibromas, 31 plexiform neurofibromas, and 16 MPNSTs
Supplementary Table and Figures from Exposure–Response Relationships of the Efficacy and Safety of Ipilimumab in Patients with Advanced Melanoma
Authors: Feng Yan , Roy Amit , Masson Eric , Chen Tai-Tsang , Humphrey Rachel , Weber Jeffrey S.
Published: April 2023

Supplementary Table and Figures - PDF file 297K, Supporting data related to the covariates included in the exposure-response analyses
Supplementary Figure 1 from Anti-PD-1 Antibody Therapy Potently Enhances the Eradication of Established Tumors By Gene-Modified T Cells
Authors: John Liza B. , Devaud Christel , Duong Connie P.M. , Yong Carmen S. , Beavis Paul A. , Haynes Nicole M. , Chow Melvyn T. , Smyth Mark J. , Kershaw Michael H. , Darcy Phillip K.
Published: April 2023

Supplementary Figure 1 - PDF file 73K, Tumor cells express high levels of PD-L1
Supplementary Figure 1 from Measles Virus Vaccine–Infected Tumor Cells Induce Tumor Antigen Cross-Presentation by Human Plasmacytoid Dendritic Cells
Authors: Guillerme Jean-Baptiste , Boisgerault Nicolas , Roulois David , Ménager Jérémie , Combredet Chantal , Tangy Frédéric , Fonteneau Jean-François , Gregoire Marc
Published: April 2023

AVI file - 14040K, Supplemental Figure 1: infection of the mesothelioma cell line Meso13 by MV-eGFP. Meso13 mesothelioma cell line was cocultured 2 hours with MV-eGFP and then washed (MOI=1). Sixteen hours later, fluorescence microscopy video was performed with a picture taken every 15 minutes with a time-lapse confocal microscope (Nikon).
Supplementary Figure S1 from Distinction between Asymptomatic Monoclonal B-cell Lymphocytosis with Cyclin D1 Overexpression and Mantle Cell Lymphoma: From Molecular Profiling to Flow Cytometry
Authors: Espinet Blanca , Ferrer Ana , Bellosillo Beatriz , Nonell Lara , Salar Antonio , Fernández-Rodríguez Concepción , Puigdecanet Eulàlia , Gimeno Javier , Garcia-Garcia Mar , Vela Maria Carmen , Luño Elisa , Collado Rosa , Navarro José Tomás , de la Banda Esmeralda , Abrisqueta Pau , Arenillas Leonor , Serrano Cristina , Lloreta Josep , Miñana Belén , Cerutti Andrea , Florensa Lourdes , Orfao Alberto , Sanz Ferran , Solé Francesc , Dominguez-Sola David , Serrano Sergio
Published: April 2023

PDF file 122K, Absolute lymphocyte counts in peripheral blood from MALD1 individuals over time
Supplementary Table 3 from The Histone Deacetylase Inhibitor Abexinostat Induces Cancer Stem Cells Differentiation in Breast Cancer with Low Xist Expression
Authors: Salvador Marion A. , Wicinski Julien , Cabaud Olivier , Toiron Yves , Finetti Pascal , Josselin Emmanuelle , Lelièvre Hélène , Kraus-Berthier Laurence , Depil Stéphane , Bertucci François , Collette Yves , Birnbaum Daniel , Charafe-Jauffret Emmanuelle , Ginestier Christophe
Published: April 2023

PDF file 54K, Karyotypes of BCLs
Supplementary Figure 1 from CTLA4 Blockade Broadens the Peripheral T-Cell Receptor Repertoire
Authors: Robert Lidia , Tsoi Jennifer , Wang Xiaoyan , Emerson Ryan , Homet Blanca , Chodon Thinle , Mok Stephen , Huang Rong Rong , Cochran Alistair J. , Comin-Anduix Begoña , Koya Richard C. , Graeber Thomas G. , Robins Harlan , Ribas Antoni
Published: April 2023

PDF file - 411KB, Scatter plots for all patients with a rank-rank analysis . For every GA patient a dot plot was generated ranking each single clone according to abundance in baseline (x axis) and post-treatment (y axis). Values range from highest frequency (0) to lowest frequency.
Supplementary Figure 2 from Lung Cancers with Concomitant EGFR Mutations and ALK Rearrangements: Diverse Responses to EGFR-TKI and Crizotinib in Relation to Diverse Receptors Phosphorylation
Authors: Yang Jin-Ji , Zhang Xu-Chao , Su Jian , Xu Chong-Rui , Zhou Qing , Tian Hong-Xia , Xie Zhi , Chen Hua-Jun , Huang Yi-Sheng , Jiang Ben-Yuan , Wang Zhen , Wang Bin-Chao , Yang Xue-Ning , Zhong Wen-Zhao , Nie Qiang , Liao Ri-Qiang , Mok Tony S. , Wu Yi-Long
Published: April 2023

PDF file - 253KB, Representative IHC graphs of EGFR, p-EGFR, ALK, p-ALK in EGFR-mutant/ALK-negative, EGFR-WT/ALK-positive tumors, and EGFR-WT/ALK-negative tumors.
Supplementary Figure 6 from The Histone Deacetylase Inhibitor Abexinostat Induces Cancer Stem Cells Differentiation in Breast Cancer with Low Xist Expression
Authors: Salvador Marion A. , Wicinski Julien , Cabaud Olivier , Toiron Yves , Finetti Pascal , Josselin Emmanuelle , Lelièvre Hélène , Kraus-Berthier Laurence , Depil Stéphane , Bertucci François , Collette Yves , Birnbaum Daniel , Charafe-Jauffret Emmanuelle , Ginestier Christophe
Published: April 2023

PDF file 85K, Histone deacetylase inhibitors target the CSC population in lowdose sensitive BCLs
Supplementary Figure 4 from Frequent Overexpression of HMGA2 in Human Atypical Teratoid/Rhabdoid Tumor and Its Correlation with let-7a3/let-7b miRNA
Authors: Zhang Keqiang , Gao Hanlin , Wu Xiwei , Wang Jinhui , Zhou Wendi , Sun Guihua , Wang Jinghan , Wang Yafan , Mu Bing , Kim Charles , Chu Peiguo , Ho Donald M. , Ann David K. , Wong Tai-Tong , Yen Yun
Published: April 2023

PDF file - 224K, Figure S4. Impact of let-7 miRNA and HMGA2 on proliferation and colony formation of G401 cells. A. Let-7 inhibitors up-regulated HMGA2 and promoted cell proliferation, and B. Overexpression HMGA2 increased colony formation of G401 cells, *: p < 0.05, compared with G401 cells transfected with control smRNA.
Supplementary Figure 1 from Frequent Overexpression of HMGA2 in Human Atypical Teratoid/Rhabdoid Tumor and Its Correlation with let-7a3/let-7b miRNA
Authors: Zhang Keqiang , Gao Hanlin , Wu Xiwei , Wang Jinhui , Zhou Wendi , Sun Guihua , Wang Jinghan , Wang Yafan , Mu Bing , Kim Charles , Chu Peiguo , Ho Donald M. , Ann David K. , Wong Tai-Tong , Yen Yun
Published: April 2023

PDF file - 1045K, Figure S1. The comparability of whole exome sequencing for saliva and FFPE AT/RT tissue of the adult patient. The sequencing coverage folds for each chromosome of A. saliva genomic DNA and B. AT/RT genomic DNA.
Supplementary Figure 1 from Phase II Results of Dovitinib (TKI258) in Patients with Metastatic Renal Cell Cancer
Authors: Escudier Bernard , Grünwald Viktor , Ravaud Alain , Ou Yen-Chuan , Castellano Daniel , Lin Chia-Chi , Gschwend Jürgen E. , Harzstark Andrea , Beall Sarah , Pirotta Nicoletta , Squires Matthew , Shi Michael , Angevin Eric
Published: April 2023

PDF file - 57KB, Supplemental Figure 1 contains the longitudinal plot of model-adjusted fold change from baseline for plasma VEGF.
Supplementary Fig. 5 from Dual Targeting of HER2-Positive Cancer with Trastuzumab Emtansine and Pertuzumab: Critical Role for Neuregulin Blockade in Antitumor Response to Combination Therapy
Authors: Phillips Gail D. Lewis , Fields Carter T. , Li Guangmin , Dowbenko Donald , Schaefer Gabriele , Miller Kathy , Andre Fabrice , Burris Howard A. , Albain Kathy S. , Harbeck Nadia , Dieras Veronique , Crivellari Diana , Fang Liang , Guardino Ellie , Olsen Steven R. , Crocker Lisa M. , Sliwkowski Mark X.
Published: April 2023

PDF file 238K, Kaplan-Meier plots of time-to-tumor doubling in Calu-3 (A) and KPL-4 (B) xenograft models after treatment with T-DM1 and pertuzumab
Supplementary Table 2 from Human Melanoma Metastases Demonstrate Nonstochastic Site-Specific Antigen Heterogeneity That Correlates with T-cell Infiltration
Authors: Bartlett Edmund K. , Fetsch Patricia A. , Filie Armando C. , Abati Andrea , Steinberg Seth M. , Wunderlich John R. , White Donald E. , Stephens Daniel J. , Marincola Francesco M. , Rosenberg Steven A. , Kammula Udai S.
Published: April 2023

PDF file - 47K, Individual dendrogram distance matrices for the melanoma differentiation antigens. Dendrogram distant matrices calculated from DendroUPGMA.
Supplementary Figure 1 from Human Melanoma Metastases Demonstrate Nonstochastic Site-Specific Antigen Heterogeneity That Correlates with T-cell Infiltration
Authors: Bartlett Edmund K. , Fetsch Patricia A. , Filie Armando C. , Abati Andrea , Steinberg Seth M. , Wunderlich John R. , White Donald E. , Stephens Daniel J. , Marincola Francesco M. , Rosenberg Steven A. , Kammula Udai S.
Published: April 2023

PDF file - 73K, MDA and MHC II expression demonstrates a site cluster-specific pattern. (A) The distribution of antigen expression for each anatomic site cluster. The p-values indicate the probability that no variability exists across the site clusters as determined by the Kruskal-Wallis test.
Supplementary Table S2 from Novel Methylation Biomarker Panel for the Early Detection of Pancreatic Cancer
Authors: Yi Joo Mi , Guzzetta Angela A. , Bailey Vasudev J. , Downing Stephanie R. , Van Neste Leander , Chiappinelli Katherine B. , Keeley Brian P. , Stark Alejandro , Herrera Alexander , Wolfgang Christopher , Pappou Emmanouil P. , Iacobuzio-Donahue Christine A. , Goggins Michael G. , Herman James G. , Wang Tza-Huei , Baylin Stephen B. , Ahuja Nita
Published: April 2023

- PDF file 86K, Supplementary Table S2. BNC1 and ADAMTS1 Gene expression changes in pancreatic cancers from previously published microarray dataset
Supplementary Table S1 from Novel Methylation Biomarker Panel for the Early Detection of Pancreatic Cancer
Authors: Yi Joo Mi , Guzzetta Angela A. , Bailey Vasudev J. , Downing Stephanie R. , Van Neste Leander , Chiappinelli Katherine B. , Keeley Brian P. , Stark Alejandro , Herrera Alexander , Wolfgang Christopher , Pappou Emmanouil P. , Iacobuzio-Donahue Christine A. , Goggins Michael G. , Herman James G. , Wang Tza-Huei , Baylin Stephen B. , Ahuja Nita
Published: April 2023

- PDF file 64K, Supplementary Table S1. Primers used for MSP, RT-PCR, Bisulfite sequencing analyses
Supplementary Figure 2 from Occurrence of Tertiary Lymphoid Tissue Is Associated with T-Cell Infiltration and Predicts Better Prognosis in Early-Stage Colorectal Cancers
Authors: Di Caro Giuseppe , Bergomas Francesca , Grizzi Fabio , Doni Andrea , Bianchi Paolo , Malesci Alberto , Laghi Luigi , Allavena Paola , Mantovani Alberto , Marchesi Federica
Published: April 2023

PDF file - 1518K, TLT in the mucosa of mice subjected to the AOM/DSS protocol.
Supplementary Fig S3 from Novel Methylation Biomarker Panel for the Early Detection of Pancreatic Cancer
Authors: Yi Joo Mi , Guzzetta Angela A. , Bailey Vasudev J. , Downing Stephanie R. , Van Neste Leander , Chiappinelli Katherine B. , Keeley Brian P. , Stark Alejandro , Herrera Alexander , Wolfgang Christopher , Pappou Emmanouil P. , Iacobuzio-Donahue Christine A. , Goggins Michael G. , Herman James G. , Wang Tza-Huei , Baylin Stephen B. , Ahuja Nita
Published: April 2023

- PDF file 57K, Supplemental Figure S3. Kaplan-Meier Curve of Overall Survival Characterized by ADAMTS1 Methylation
Supplementary Table 2 from Characterization and Clinical Relevance of ALDHbright Populations in Prostate Cancer
Authors: Le Magnen Clémentine , Bubendorf Lukas , Rentsch Cyrill A. , Mengus Chantal , Gsponer Joel , Zellweger Tobias , Rieken Malte , Thalmann George N. , Cecchini Marco G. , Germann Markus , Bachmann Alexander , Wyler Stephen , Heberer Michael , Spagnoli Giulio C.
Published: April 2023

PDF file, 46K, Analysis of the expression of ALDH specific isoforms in BPH and PCa surgical specimens.
Supplemental Figure 1 from Influence of Human OATP1B1, OATP1B3, and OATP1A2 on the Pharmacokinetics of Methotrexate and Paclitaxel in Humanized Transgenic Mice
Authors: van de Steeg Evita , van Esch Anita , Wagenaar Els , Kenworthy Kathryn E. , Schinkel Alfred H.
Published: April 2023

PDF file - 63K, Ponceau S staining confirming equal protein loading in the Western blot analyses presented in Figure 1
Supplementary Figure S5 from GKN1–miR-185–DNMT1 Axis Suppresses Gastric Carcinogenesis through Regulation of Epigenetic Alteration and Cell Cycle
Authors: Yoon Jung Hwan , Choi Yoo Jin , Choi Won Suk , Ashktorab Hassan , Smoot Duane T. , Nam Suk Woo , Lee Jung Young , Park Won Sang
Published: April 2023

Supplementary Figure S5 - PDF file 3120K, Effects of GKN1 on miR-185 expression
Supplementary Figure Legends from A Phase 1, Dose-Escalation, Pharmacokinetic and Pharmacodynamic Study of BIIB021 Administered Orally in Patients with Advanced Solid Tumors
Authors: Saif Muhammad Wasif , Takimoto Chris , Mita Monica , Banerji Udai , Lamanna Nicole , Castro Januario , O'Brien Susan , Stogard Christopher , Von Hoff Daniel
Published: April 2023

Supplementary Figure Legends - PDF file 90K, supplementary figures legends
CCR Translation for This Article from A Phase 1, Dose-Escalation, Pharmacokinetic and Pharmacodynamic Study of BIIB021 Administered Orally in Patients with Advanced Solid Tumors
Authors: Saif Muhammad Wasif , Takimoto Chris , Mita Monica , Banerji Udai , Lamanna Nicole , Castro Januario , O'Brien Susan , Stogard Christopher , Von Hoff Daniel
Published: April 2023

CCR Translation for This Article from A Phase 1, Dose-Escalation, Pharmacokinetic and Pharmacodynamic Study of BIIB021 Administered Orally in Patients with Advanced Solid Tumors
Supplementary Table 1 from Id1-Induced IGF-II and Its Autocrine/Endocrine Promotion of Esophageal Cancer Progression and Chemoresistance—Implications for IGF-II and IGF-IR–Targeted Therapy
Authors: Li Bin , Tsao Sai Wah , Chan Kwok Wah , Ludwig Dale L. , Novosyadlyy Ruslan , Li Yuk Yin , He Qing Yu , Cheung Annie L.M.
Published: April 2023

PDF file - 8KB, Immunohistochemical analysis of expression levels of Id1, IGF2, and p-AKT in human ESCC specimens.
Supplementary Figure 2 from Targeting the Phosphoinositide 3-Kinase p110-α Isoform Impairs Cell Proliferation, Survival, and Tumor Growth in Small Cell Lung Cancer
Authors: Wojtalla Anna , Fischer Barbara , Kotelevets Nataliya , Mauri Francesco A. , Sobek Jens , Rehrauer Hubert , Wotzkow Carlos , Tschan Mario P. , Seckl Michael J. , Zangemeister-Wittke Uwe , Arcaro Alexandre
Published: April 2023

PDF file - 46K, PI3K inhibition increases autophagy in SCLC
Supplementary Figure Legend from Surveillance of the Tumor Mutanome by T Cells during Progression from Primary to Recurrent Ovarian Cancer
Authors: Wick Darin A. , Webb John R. , Nielsen Julie S. , Martin Spencer D. , Kroeger David R. , Milne Katy , Castellarin Mauro , Twumasi-Boateng Kwame , Watson Peter H. , Holt Rob A. , Nelson Brad H.
Published: April 2023

PDF file - 102K
Supplementary Figure 4 from Surveillance of the Tumor Mutanome by T Cells during Progression from Primary to Recurrent Ovarian Cancer
Authors: Wick Darin A. , Webb John R. , Nielsen Julie S. , Martin Spencer D. , Kroeger David R. , Milne Katy , Castellarin Mauro , Twumasi-Boateng Kwame , Watson Peter H. , Holt Rob A. , Nelson Brad H.
Published: April 2023

PDF file - 63K, Defining the HLA restriction of Clone 1.